UK markets closed

Emergent BioSolutions Inc. (EBS)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
6.17+0.13 (+2.15%)
At close: 04:00PM EDT
6.16 -0.01 (-0.16%)
After hours: 07:36PM EDT
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Assets
Current assets
Cash
Cash and cash equivalents
111,700
642,600
576,100
621,300
-
Total cash
111,700
642,600
576,100
621,300
-
Net receivables
141,800
102,700
230,500
172,700
-
Inventory
328,900
350,700
344,500
307,000
-
Other current assets
47,900
57,900
70,200
-
-
Total current assets
679,500
1,210,400
1,269,900
1,195,900
-
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
794,200
1,201,400
1,119,200
903,200
-
Accumulated depreciation
-411,400
-383,800
-319,100
-259,100
-
Net property, plant and equipment
382,800
817,600
800,100
644,100
-
Goodwill
0
218,200
224,900
266,700
-
Intangible assets
566,600
728,800
604,600
663,100
-
Other long-term assets
194,300
191,300
58,200
113,400
-
Total non-current assets
1,143,700
1,955,900
1,687,800
1,687,300
-
Total assets
1,823,200
3,166,300
2,957,700
2,883,200
-
Liabilities and stockholders' equity
Liabilities
Current liabilities
Current debt
413,700
957,300
31,600
33,800
-
Accounts payable
112,200
103,500
128,900
136,100
-
Accrued liabilities
18,600
34,900
51,700
46,900
-
Other current liabilities
32,700
45,900
73,100
83,100
-
Total current liabilities
651,300
1,228,900
374,000
384,500
-
Non-current liabilities
Long-term debt
446,500
448,500
809,400
841,000
-
Deferred tax liabilities
47,200
59,700
93,300
53,200
-
Deferred revenues
-
-
4,700
55,500
85,600
Other long-term liabilities
28,900
41,500
69,500
102,000
-
Total non-current liabilities
522,600
549,700
972,200
1,051,700
-
Total liabilities
1,173,900
1,778,600
1,346,200
1,436,200
-
Stockholders' equity
Common stock
100
100
100
100
-
Retained earnings
-21,800
738,700
950,300
726,900
-
Accumulated other comprehensive income
-5,700
3,100
-16,100
-25,300
-
Total stockholders' equity
649,300
1,387,700
1,611,500
1,447,000
-
Total liabilities and stockholders' equity
1,823,200
3,166,300
2,957,700
2,883,200
-